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ABSTRACT
Candida albicans is a classical example of causative agent for opportunistic fungal 
infection. Normally, it colonizes skin, gastrointestinal tract, genital, and mucosal 
membranes, but in certain condition it may responsible for diseases. This phenomenon 
was mainly associated with immunological status of the host. However, there were 
findings that showed the possibility of putative virulence factors work on the transition 
of commensally to pathogenic role of the yeast. In this review, some virulence factors 
were discussed. Indeed, there were factors that may be considered as putative virulence 
factors of C. albicans. 
ABSTRAK
Candida albicans adalah contoh klasik jamur penyebab infeksi oportunistik. Jamur ini 
biasa berkoloni di kulit, traktus gastrointestinal, genital, dan membran mukosa sebagai 
komensal. Namun demikian, pada kondisi tertentu jamur ini dapat menjadi agen penyebab 
infeksi. Fenomena ini biasanya dihubungkan dengan status imunitas dari inang. Akan 
tetapi, terdapat banyak laporan yang mengindikasikan adanya faktor virulensi yang 
bekerja pada proses transisi dari komensal menjadi patogenik ini. Pada kajian pustaka ini, 
beberapa kandidat faktor virulensi C. albicans didiskusikan. 
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INTRODUCTION
Candida albicans is a classical example 
of causative agent for opportunistic fungal 
infection. There are 17 species member of 
genus Candida e.g: C. albicans, C. glabrata, 
C. parapsilosis and C. tropicaliswhich are 
commonly related with human diseases.1 The 
clinical manifestations of C. albicans infection 
are related with the host immune response. 
The risk of infection is higher in the individual 
with risk factors related with immune 
response deterioration. It is well known that 
C. albicans is a flora normal in the skin, 
gastrointestinal tract, genital, and mucosal 
membranes, which is not regularly recognized 
as a pathogen in immunocompetence human 
being.2Candida albicans may be cultured on 
several media, such as Sabouraud’s dextrose 
agar. It grow very fast, unlike other known 
fungus. The yeast colony is white to cream 
colored, smooth, glabrous and yeast-like 
in appearance. Microscopic morphology 
shows spherical to subspherical budding 
yeast-like cells or blastoconidia, 2.0-7.0 x 
3.0-8.5 um in size. Assimilation test showed 
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positive for: Glucose, Maltose, Galactose, 
Trehalose, Sucrose (some negative), 
D-Xylose, Soluble Starch, D-Mannitol, and 
D-Glucitol (Delayed).3 Candida albicans 
may be identified using several methods, i.e. 
microscopic, morphological observation on 
selective media, germ tube test, assimilation 
test, and nucleic acid base identification 
(FIGURE 1). 
Candida albicans is the most common 
fungal causative agent for urinary tract 
infection. In general, C. albicans is unusual 
cause of urinary tract infection in healthy 
individual. However, it was reported common 
in hospitalized patients, who have risk factors, 
such as urinary tract structural problems. 
The infection may associate with invasion in 
antegrade form blood stream or retrograde 
from urethra and bladder.4
A surveillance of nosocomial blood 
stream infections (BSI) report in the USA 
between April 1995 and June 1996 highlighted 
that Candida was the fourth most common 
causative agent of nosocomial BSI. Fifty-
two percent of 379 of candidemia cases were 
due to C. albicans,5 and it have reported to be 
one of the leading causes of catheter-related 
BSI.6 Candidemia affects more than250,000 
people worldwide every year and responsible 
to more than 50,000 deaths.Incidence rates of 
candidemia have been reported to be 2 - 14 
casesper 100,000 persons in population-based 
studies.7
Epidemiological data showed that Candida 
may cause wide spread of vulvovaginal 
candidiasis (VVC). VVC is most frequently 
caused by C. albicans, though other species 
are emerge.8This fungal infection affect up 
to 75% healthy women, which some of them 
develop recurrent infection, known as recurrent 
vulvovaginal candidiasis (RVVC). The 
RVVC has challenging characteristic which 
may responsible for treatment failure.9 Many 
factors work to facilitate the transtition of C. 
albicans colonization state to asymptomatic 
fungal infection, such as host susceptibility 
and host inflammatory responses, as well as 
candidal virulence factors.10,11
Candida sp are members of the oral 
microflora of humans, they are opportunistic 
pathogens that under conditions of host 
debilitation can cause an oral infections. 
Alteration of oral environment may favor the 
overgrowth of Candida, which in turn develop 
oral candidiasis. Candida sp is well known 
as pathogen responsible for oral diseases.12In 
oral fungal infection, C. albicans contributes 
near 50% of all candidiasis cases.13
Candidiasis (moniliasis) is the third 
most common superficial skin fungal 
infection after dermatophytosis and pityriasis 
versicolor.14Non-hematogenous primary skin 
infections typically occur as intertrigo in skin 
folds, which is common in obese and diabetic 
patients. Candida is knownresponsible for 
neonatal candidiasis syndrome, a widespread 
dermatitis due to Candida in neonates. The 
FIGURE 1.  Colony appearance of  C. albicans isolat-
ed from sputum which was cultured on Sa-
bouraud’s dextrose agar media, after incu-
bation in room temperature for 24 hours. 
The yeast colony appeared white to cream 
colored, smooth, glabrous and yeast-like 
in appearance.
J Med Sci, Volume 48, No. 1, January: 58-68
60
syndromes associated with contamination of 
amniotic fluid, in which limited to the skin for 
healthy-term infants.15
There were other various systems and 
organs may be involved for C. albicans 
infection, such as: liver, spleen, larynx, 
lungs, bones, joints, pancreas, peritoneum, 
endocardium, eyes, and meninges.15 The C. 
albicans clinical manifestation is considered 
as transformation from commensal of the fungi 
to infection state. There are many factors work 
for the transformation, including virulence 
factors of C. albicans. This review aims to 
discuss several putative virulence factors of 
C. albicans, which isimportant to give more 
understanding and insight concerning to 
the management of candidiasis which may 
involve various organs. 
DISCUSSION
There are various putative virulence 
factors of C. albicans documented, 
such as: adherence of the fungi to the 
host’s surfaces, production of hydrolytic 
enzymes, dimorphism, galvanotropism and 
thigmotropism, phenotypic switching, biofim 
formation, and evasion to the host immune 
response. 
Adherence
Candida albicans is able to adhere 
to various tissues andinanimate surfaces. 
For example, buccaland vaginal epithelial 
cells, corneocytes, cultured cells (HeLa 
and HEp-2) surface, as well as biomaterial 
surface.4Adherence is the first step of C. 
albicans infection in the oral and other 
surfaces. It is an essential stage for the 
persistence of the organism in the host, as 
shown by the report that number of C. albicans 
cells adhered to epithelial cells is significantly 
higher in the chronic periodontitis group 
than in the control group.16 Experimentation 
using saliva – coated hydroxiapatite (SHA) 
beads showed that C. albicansstrains which 
associated with oral candidiasis adhere 
better to SHA beads than less pathogenic 
strains.17,18Adhesins are the fungal surface 
molecules that mediate binding of C. albicans 
to the surface of human or microbes cells, inert 
polymers, or proteins.19 There are candidate 
genes putatively considered as encoding 
adhesins such as: ALA1, ALS1, Hwp1, INT1, 
MMT1, PMT1, PMT6 and Als1p.18-21Other 
putative adhesins are mannan, chitin, factor 
6 oligomannosaccharide, 66-kDa fimbrial 
protein, fibronectin binding protein, iC3b 
binding protein, fucose binding protein, 
GIcNAc or glucosamine, and secreted aspartyl 
proteinase (SAP).18,19Efforts to understand 
C. albicans adhesins are hampered by the 
limitation of consistency in several studies, 
such as: different strain showed different 
adherence specificities and strength, technical 
limitation of maintaining adhesins expression 
in vitro, and disagreement of viability yeast 
effect to the adherence capability.18
Production of hydrolytic enzymes
Candida albicans is producing many 
hydrolytic enzymes that facilitate its 
commensally and pathogenic characteristics: 
adherence tohost tissue and inert particles, 
rupture of host cell membranes, invasion 
of mucosal surfaces and blood vessels, and 
evasion of the host’s immune response. 
There are three major enzymes produced 
by C. albicans: SAP, phospholipases,and 
hemolysins.4,22
Secreted aspartyl proteinases
The Sapproteins of C. albicans were 
encoded by a family of 10 SAP genes: SAP1, 
SAP2, SAP3, SAP4, SAP5, SAP6, SAP7, SAP8, 
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SAP9, and SAP10. The Sap1 to Sap10 proteins 
are 35- 50 kDa in size and responsible for all 
of the extracellular proteolytic activity of C. 
albicans.The characteristic of Sap proteins 
are not yet clearly elucidated, though current 
evidences showed that the main roles of the C. 
albicans Saps are to provide nutrition for the 
yeast cells, to aid penetration and invasion, 
and to evade host immune responses.23 Sap 
degrades proteins related to structural and 
immunologic defenses, such as collagen, 
keratin, mucin, antibodies, complement, and 
cytokines, during tissue invasion.4,24 The 
presence of genes and secretion of aspartic 
proteases by C. albicans was demonstrated 
to be one of the virulence factors.25It was 
observed that the virulence of C. albicans 
associated with the level of Sap activity and 
number of SAP genes. C. albicans isolated 
from patients who has clinical manifestation, 
have higher proteolytic activity compare to 
those obtained from healthy individual.23,26,27 
Saps expression by C. albicans is regulated by 
several factors, such as nutritional condition, 
pH, temperature, and growth phase of the 
yeast. Studies on Saps expression revealed 
that there are contradiction conclusions on 
Sap expression in various in vivo experiments. 
Sap protein specific types is claimed to be 
correlated with organ involve, infection 
locataion, and environmental factors in 
every study. However, because of different 
techniques and experimental model, effort to 
formulate conclusive statement on which type 
of Sap dominantly active in each candidiasis 
cases -- for example which Saps work in oral 
candidiasis, vaginal candidiasis, or systemic 
candidiasis -- is a very difficult task.28
Phospholipases
Phospholipases hydrolyze glycerophos-
pholipids, which are major components 
of mammalian cell membranes. It cleaves 
fatty acids from phospholipids which in 
turn destabilizing the membranes.4,29,30There 
are seven phospholipase genes have been 
identified i.e. PLA, PLB1, PLB2, PLC1, 
PLC2, PLC3 and PLD1.  However, the role 
of the enzymes encoded by these genes 
remains unclear.31Evidence of phospholipase 
act as virulence factor was obtained from 
comparative study conducted by Ibrahim et 
al.32 in which one series of C. albicans obtained 
from candidemia patients compared with 
isolates obtained from oral cavity of healthy 
individuals. It was shown that isolate from 
candidemia cases have higher phospholipase 
activity, which reflected the virulence of these 
isolates. 
Hemolysins
Hemolytic capacity, which is served by 
hemolysins enzyme,  is an important putative 
virulence factor of the genus Candida to 
acquire iron from host tissues, which then is 
used by the yeast for metabolism,  growth 
and invasion during host infection.33,34In 
the human being, iron is found in several 
proteins, including hemoglobin located in 
the erythrocytes. Candida albicans capable 
to bind to erythrocytes, then hemolysis factor 
will destroy the erythrocytes. However, 
the mechanism of hemolysis  caused by C. 
albicans remain unclear.33,34The hemolytic 
activity may be observed readily by culturing 
C. albicans on the blood agar media. 
It was reported that 98.5% of C. albicans 
isolates have hemolytic activity including 
alpha, beta,and gamma hemolysis in aerobic 
condition.35 However, the hypothesis of 
hemolysins is a virulence factor of C. 
albicansstill controversial. Study on C. 
albicans isolated from HIV patients and 
healthy individual showed that the hymolytic 
activity were higher in isolates which were 
obtained from healthy individual.36 This 
finding add another insight that hemolytic 
capacity may not be concidered as virulence 
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factor without  presence of other virulence 
factors. 
Dimorphism
Candida albicans able to grow in yeast 
and mold forms. The transition between yeast 
and hyphal forms istermed as dimorphism.
Accordingly it clasified as dimorphic 
fungus.In the yeast form, it may undergo 
budding, whereas in mould form, it may 
produce new mycelia, or yeast like form. The 
transformation between two morphologies can 
be induced in vitro with several environmental 
conditions, such as pH, temperature, or 
chemicals.37 Dimorphism of C. albicans is a 
unique characteristic for pathogenicity of the 
yeast (FIGURE 2). Both morphologies have 
their own function to support its virulence.38 
The hyphal form has been reported to be more 
invasive than the yeast form.  It was shown 
that three C. albicans mutant strains which 
compromised in the ability to form hyphae 
(efg1∆/efg1∆, flo8∆/flo8∆, and cph1∆/cph1∆ 
efg1∆/efg1∆) were significantly less virulence 
in C. elegans infection  model.39 Whereas, the 
yeast form is proposed as theform primarily 
involved in dissemination of the fungus.40 
However, another group found that transition 
of C. albicans morphology to yeast form may 
not the only factor regulate dissemination 
from the gastrointestinal tract to the other 
organs in invasive C. albicans infection.42
More than 40 genes were identified 
responsible for dimorphism regulation, 
mainly hyphal formation.42,43 Those genes 
are working in different stages of infection. 
Dimorphism of C. albicansis important 
for pathogenicity at both superficial and 
systemicinfections. It should be noted that 
both yeast and filamentous form of C. 
albicans were found in infected tissues. The 
capability of C. albicans to undergo transition 
from yeast to filamentous form contribute to 
numerous nature of its infection stages, such 
as adherence to epithelial and endothelial 
cells, intercellular invasion, iron acquisition 
from intracellular host sources, biofilm 
formation, as well as escape from phagocytes 
and immune evasion.44,45
FIGURE 2. Microscopic appearance of C. albicans 
found in the sputum of patient, after Gram 
staining. The dimorphism of C. albicans 
budding yeast, pseudohyphae, and true 
hyphae were observed.  
Phenotypic switching
Candida albicans has capability to 
undergo phenotypic switching that is 
commonly called as white-opaque phenotypic 
switching.A small proportion of C. albicans 
isolates, which are homozygous at the mating 
type locus (MTL, a/a or α/ α), able to switch 
between two distinct cell morphologies: white 
and opaque. It is not known how white-opaque 
switching has never been observed in C. 
albicans strains that have heterozygous MTL 
genotypes (a/α), though they have all essential 
genes for white-opaque switching.46FIGURE 
3 shows different cell morphology between 
white and opaque cells. The white cells appear 
round and bright under microspcope, while 
opaque cells appear darker, polymorphic and 
oval. The white-opaqe cells may be observed 
also in their colonies by using simple phloxin 
B suplementation in the media.36Furthermore, 
63
Wibawa, The role of virulence factors in Candida albicans pathogenicity
white and opaque phenotypes show different 
cellular and colony appearances, gene 
expression profiles, mating ability and 
virulence.47
White and opaque cells differ in their 
mating capability as well as expression of 
genes that are unrelated with mating process, 
such as adhesins and metabolic genes. Opaque 
cells are better colonizers of the skin, but they 
are less virulent than white cells in a mouse 
model of disseminated candidiasis.48Opaque 
cell formed hyphae in very low level  in 
the suspension cultures, in which white 
cell C. albicans will able to form hyphae. 
This finding indicated that opaque cell less 
virulent compare to white cells. When opaque 
cells able to form hyphae, morphologically 
similar with hypae of white cells. However, 
genetically still distinc to the hypae formed by 
white cells.49White-opaque switching occurs 
at a low frequencyin C. albicans,36but certain 
environmental conditions can drive the switch 
from one phase to the other. Although opaque 
cells are less frequently cause systemic 
infection than white cells, they have better 
optimazion for colonization, such as on the 
skin.50White-opaque switching has been 
shown also to affect several virulence factors, 
such as susceptibility to antifungal drugs, 
proteinase activity, antigenicity, and adhesion 
of C. albicans.4
Biofilm formation
Biofilm is a structure made of microbes 
consortium supported with extracellular matrix 
which attach to the surface of living matter 
or inanimate structure. Candida albicans 
is well known yeast that able to develop 
biofilm. Biofilm of C. albicans is notorious 
because of its deleterious consequences, 
such as leads to antifungal resistance, give a 
asylum to the yeast because of ability to make 
evasion against immune surveillance, and act 
as perfect reservoir for source of infection, 
as well as several advantages in the fungal’s 
perspective: protection from the environment, 
resistance of physical and chemical stress, 
metabolic cooperation, and a community-
based regulation of gene expression.Indeed, 
biofilm formation represents one of the 
putative virulence factors contributing to the 
pathogenesis of candidiasis.51-53 The biofilm 
of C. albicans may need special attention 
since antifungal may not work properly in 
FIGURE 3. Microscopic appearance of C. albicans. (A) Opaque cells appear dark, oval and 
polymorphic. (B) White cells appear circular and bright. Some of them produce 
hypae when incubated in 37°C for 90 minutes with supplementation of serum 
(germ tube test).
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the biofilm setting. Anti-biofilm substance 
need to be invented in the near future.54 
Biofilm formation is a dynamic process which 
is started with adherence of planctonic yeast 
cells to the surface, proliferation of the yeast 
cells, formation of hyphae, and accumulation 
of extracellular matrix. Then the maturation of 
the biofilm is complete. Moreover, yeast cells 
which construct the biofilm may be detached 
and disperse to other part of the body which 
may go to the new focal infection.51,55 There 
are two types of C. albicans cells involve in 
the biofilm formation:small yeast-form cells 
(blastospores), and long tubular hyphal cells. 
The two cell types have their specific role in 
biofilm formation.55 Study on two series 
C. albicans from HIV infected and healthy 
individuals showed that frequency of C. 
albicans isolates which able to form biofilm 
is comparable between two groups.36The 
result showed to us that biofilm as a putative 
virulence factor may not work alone. It may 
work in a concert with other virulence factors. 
Evasion to the host immune responses
Human immune response against C. 
albicans occurs through several mechanisms, 
comprising innate and adaptive immune 
response. The innate immune response is 
nonspecific and broad. This is the first line 
of host defense against potentially harmful 
microbes. Innate immunity comprises of a 
group of soluble (complement) and cellular 
(neutrophil, macrophage) components. 
Whereas, the adaptive immune response 
recognizes specific antigenicmoieties, 
resulting to the development of a targeted 
immuneresponse.56 Several mechanisms 
have been proposed to explain the mechanism 
of C. albicans evade from the host immune 
response, which is considered as virulence 
factor of the yeast. Experiment in TLR2(-
/-) mice showed that C. albicans induce 
immunosuppression through TLR2-mediated 
IL-10 release, and this leads togeneration of 
CD4+CD25+ T-regulatory cells with immuno 
suppressive potential.57Candida albicanswas 
shown capable to bind thrombocytesvia 
fibrinogen ligands in the blood stream. This 
may result to the yeast cells being surrounded 
by a group of thrombocytes, which in turn 
may camouflage them from the immune 
system during dissemination through the 
blood stream.4
CONCLUSION 
Candida albicans is an opportunistic 
pathogen which responsible for various 
diseases associated with several organs. It 
pathogenicity is not solely because of the 
impairment of host immune response. Some 
putative virulence factors may work in 
concert to facilitate the yeast transition form 
commensal to pathogenic. Now, it is important 
to further analyze the role of each virulence 
factors in every step of the transition, in order 
to improve the management of the candidiasis 
in the near future. 
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